Mayooran Shanmuganathan

Author

Also Known As

C.T.S. Lim, L Shainberg, M Shanmuganathan, M. Shanmuganathan, Mayooran SHANMUGANATHAN, Mayooran Shanmuganathan, Nikolaidou, C, Oxford Acute Myocardial Infarction (OxAMI) Study, Roberto Scarsini, Shanmuganathan, M

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Oxford John Radcliffe Hospital Oxford BioMedica (United Kingdom)British Heart Foundation National Institute for Health Research

About

Mayooran Shanmuganathan is an author at University of Oxford specializing in medicine, cardiovascular disease, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	271
2	Public Health	2	2	196
3	Biomedical Engineering	2	2	196
4	Health Sciences	1	1	75
5	Exercise Physiology	1	1	75

Mayooran Shanmuganathan

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge Betty Raman, Mark Philip Cassar, Elizabeth M. Tunnicliffe, EClinicalMedicine	2021	607
Coronary Microvascular Dysfunction Assessed by Pressure Wire and CMR After STEMI Predicts Long-Term Outcomes Roberto Scarsini, Mayooran Shanmuganathan, Giovanni Luigi De Maria, JACC. Cardiovascular imaging HypertensionPressure WireCardiovascular DiseaseMyocardial InfarctionCoronary Microvascular Dysfunction	2021	100
Angiography-derived index of microcirculatory resistance (IMRangio) as a novel pressure-wire-free tool to assess coronary microvascular dysfunction in acute coronary syndromes and stable coronary artery disease Roberto Scarsini, Mayooran Shanmuganathan, Rafail A. Kotronias, International journal of cardiac imaging HypertensionCardiovascular DiseaseAtherosclerosisMyocardial InfarctionMicrovascular Dysfunction	2021	96
Neutrophils incite and macrophages avert electrical storm after myocardial infarction Jana Grune, Andrew Lewis, Masahiro Yamazoe, Nature Cardiovascular Research	2022	95
Artificial Intelligence for Contrast-Free MRI: Scar Assessment in Myocardial Infarction Using Deep Learning–Based Virtual Native Enhancement Qiang Zhang, Matthew K. Burrage, Mayooran Shanmuganathan, Circulation	2022	92
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational Study Jessica Artico, Hunain Shiwani, James Moon, Circulation	2023	84
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge Betty Raman, Mark Philip Cassar, Elizabeth M. Tunnicliffe, Mental HealthCovid-19 EpidemiologyMagnetic Resonance ImagingCovid-19Fatigue Management	2020	75
Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial Andrew Morrow, Thomas J. Ford, Kenneth Mangion, American Heart Journal	2020	67
Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure Liam S. Couch, Jan Fiedler, Giles Chick, Cardiovascular Research	2021	54

Page 1